Literature DB >> 17520258

Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease.

Lizhi Zhang1, Daniel Visscher, Charanjit Rihal, Marie-Christine Aubry.   

Abstract

Mixed connective tissue disease (MCTD) is a systemic disease seen in a group of patients with overlapping clinical features of lupus, scleroderma, polymyositis, and rheumatoid arthritis. A defining feature of MCTD is the presence of antibodies against the U1-ribonucleoprotein (U1-RNP) complex. Pulmonary hypertension is the major cause of death in MCTD. We report an autopsy case of MCTD with pulmonary hypertension. The U1-RNP antibody of this patient was 171.9 U (normal < 25.0 U). The immediate cause of death was attributed to acute pulmonary embolism at left lower lobe. A severe vasculopathy characterized by fibrotic occlusion of small veins and venules, associated with prominent capillary congestion, was consistent with pulmonary veno-occlusive disease (PVOD). This is the first case reported in which PVOD is the primary cause of pulmonary hypertension in MCTD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520258     DOI: 10.1007/s00296-007-0362-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

1.  Fatal pulmonary venoocclusive disease after use of oral contraceptives.

Authors:  J N Townend; D H Roberts; E L Jones; M K Davies
Journal:  Am Heart J       Date:  1992-12       Impact factor: 4.749

2.  Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study.

Authors:  Y Hosoda; Y Suzuki; M Takano; T Tojo; M Homma
Journal:  J Rheumatol       Date:  1987-08       Impact factor: 4.666

3.  Pulmonary veno-occlusive disease.

Authors:  C H Brown; C V Harrison
Journal:  Lancet       Date:  1966-07-09       Impact factor: 79.321

4.  Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein.

Authors:  M Okawa-Takatsuji; S Aotsuka; M Fujinami; S Uwatoko; M Kinoshita; M Sumiya
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 5.  Radiation-induced pulmonary veno-occlusive disease.

Authors:  M R Kramer; M Estenne; N Berkman; M Antoine; P de Francquen; A Lipski; D Jacobovitz; J Lafair
Journal:  Chest       Date:  1993-10       Impact factor: 9.410

6.  Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.

Authors:  M A Burdt; R W Hoffman; S L Deutscher; G S Wang; J C Johnson; G C Sharp
Journal:  Arthritis Rheum       Date:  1999-05

7.  Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.

Authors:  G G Pietra; W D Edwards; J M Kay; S Rich; J Kernis; B Schloo; S M Ayres; E H Bergofsky; B H Brundage; K M Detre
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

8.  Mixed connective tissue disease with fatal pulmonary hypertension.

Authors:  H Kobayashi; T Sano; K Ii; K Hizawa; A Yamanoi; T Otsuka
Journal:  Acta Pathol Jpn       Date:  1982-11

9.  Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.

Authors:  James R Runo; Cindy L Vnencak-Jones; Melissa Prince; James E Loyd; Lisa Wheeler; Ivan M Robbins; Kirk B Lane; John H Newman; Joyce Johnson; William C Nichols; John A Phillips
Journal:  Am J Respir Crit Care Med       Date:  2002-11-21       Impact factor: 21.405

10.  Pulmonary venoocclusive disease in pregnancy.

Authors:  E Tsou; R E Waldhorn; D M Kerwin; S Katz; J A Patterson
Journal:  Obstet Gynecol       Date:  1984-08       Impact factor: 7.661

View more
  4 in total

1.  Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.

Authors:  Keith M Wille; Nirmal S Sharma; Tejaswini Kulkarni; Matthew R Lammi; Joseph B Barney; S Christopher Bellot; Ryan S Cantor; David C Naftel; Enrique Diaz-Guzman; David C McGiffin
Journal:  Ann Am Thorac Soc       Date:  2014-11

2.  Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograft.

Authors:  R Saggar; D J Ross; R Saggar; D A Zisman; A Gregson; J P Lynch; M P Keane; S Samuel Weigt; A Ardehali; B Kubak; C Lai; D Elashoff; M C Fishbein; W D Wallace; J A Belperio
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

3.  Coexistence of five autoimmune diseases: diagnostic and therapeutic difficulties.

Authors:  Ewa Wielosz; Maria Majdan; Iwona Zychowska; Radosław Jeleniewicz
Journal:  Rheumatol Int       Date:  2008-03-05       Impact factor: 2.631

4.  Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension.

Authors:  Said Hajouli; Muhamad Alhaj Moustafa; Jessica S Wang Memoli
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.